Recent evidence suggests an imbalance of the L-arginine metabolism in cystic fibrosis (CF) airways towards arginase as the activity of arginase is upregulated and levels of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA) are increased in CF sputum. Here, NOS2 is linked to cystic fibrosis.